Overview

A Study to Compare Pharmacokinetics of GB1211

Status:
Recruiting

Trial end date:
2023-04-15

Target enrollment:

Participant gender:

Summary

This study is an open label, Randomized, Three-period, Crossover Study to Compare the Pharmacokinetics of GB1211 upon Dosing a Capsule under Fasting Condition and a Tablet under Fasting and Fed Conditions in Healthy Volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Galecto Biotech AB

Collaborator:

QPS Holdings LLC